177 related articles for article (PubMed ID: 37087550)
1. [1, 25-(OH)
Huang C; Dong R; Li Z; Yuan J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Apr; 39(4):325-331. PubMed ID: 37087550
[TBL] [Abstract][Full Text] [Related]
2. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
3. Astragaloside IV attenuates high glucose-induced EMT by inhibiting the TGF-β/Smad pathway in renal proximal tubular epithelial cells.
Wang YN; Zhao SL; Su YY; Feng JX; Wang S; Liao XM; Wang LN; Li JC; Meng P; Li HY; Zhang YF
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515466
[TBL] [Abstract][Full Text] [Related]
4. [Transforming growth factor-β1 and Snail1 mediate tubular epithelial-mesenchymal transition in diabetic rats].
Fang KY; Lou JL; Xiao Y; Shi MJ; Gui HZ; Guo B; Zhang GZ
Sheng Li Xue Bao; 2008 Feb; 60(1):125-34. PubMed ID: 18288368
[TBL] [Abstract][Full Text] [Related]
5. Pirfenidone Attenuates Renal Tubulointerstitial Fibrosis through Inhibiting miR-21.
Bi L; Huang Y; Li J; Yang X; Hou G; Zhai P; Zhang Q; Alhaji AA; Yang Y; Liu B
Nephron; 2022; 146(1):110-120. PubMed ID: 34724669
[TBL] [Abstract][Full Text] [Related]
6. BMP-7/Smads-induced inhibitor of differentiation 2 (Id2) upregulation and Id2/Twist interaction was involved in attenuating diabetic renal tubulointerstitial fibrosis.
Xiao Y; Jiang X; Peng C; Zhang Y; Xiao Y; Liang D; Shi M; Wang Y; Zhang F; Guo B
Int J Biochem Cell Biol; 2019 Nov; 116():105613. PubMed ID: 31539631
[TBL] [Abstract][Full Text] [Related]
7. [Role and mechanism of tranilast preventing the progression of tubulointerstilial fibrosis in diabetic kidney diseases].
Luo J; Li Y; Yang Y; Li J; Sun L; Duan S; Liu H; Liu F; Liu Y; Xi Y; You Y; Li H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Dec; 38(12):1233-42. PubMed ID: 24384948
[TBL] [Abstract][Full Text] [Related]
8. Beta-casomorphin-7 prevents epithelial-mesenchymal transdifferentiation of NRK-52E cells at high glucose level: Involvement of AngII-TGF-β1 pathway.
Zhang W; Song S; Liu F; Liu Y; Zhang Y
Peptides; 2015 Aug; 70():37-44. PubMed ID: 25882007
[TBL] [Abstract][Full Text] [Related]
9. Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo.
Liu P; Li F; Qiu M; He L
Diabetes Res Clin Pract; 2014 Aug; 105(2):206-16. PubMed ID: 24894085
[TBL] [Abstract][Full Text] [Related]
10. miR-136 improves renal fibrosis in diabetic rats by targeting down-regulation of tyrosine kinase SYK and inhibition of TGF-β1/Smad3 signaling pathway.
Liu L; Pang X; Shang W; Feng G; Wang Z; Wang J
Ren Fail; 2020 Nov; 42(1):513-522. PubMed ID: 32441195
[No Abstract] [Full Text] [Related]
11. Sorafenib ameliorates renal fibrosis through inhibition of TGF-β-induced epithelial-mesenchymal transition.
Jia L; Ma X; Gui B; Ge H; Wang L; Ou Y; Tian L; Chen Z; Duan Z; Han J; Fu R
PLoS One; 2015; 10(2):e0117757. PubMed ID: 25679376
[TBL] [Abstract][Full Text] [Related]
12. MiR-135a regulates renal fibrosis in rats with diabetic kidney disease through the Notch pathway.
Zhang LY; Wang Y; Yang YR; Shao JJ; Liang B
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1979-1987. PubMed ID: 32141566
[TBL] [Abstract][Full Text] [Related]
13. [p38 MAPK mediates high glucose-induced renal tubular epithelial-mesenchymal transition.].
Fang KY; Shi MJ; Xiao Y; Gui HZ; Guo B; Zhang GZ
Sheng Li Xue Bao; 2008 Dec; 60(6):759-66. PubMed ID: 19082432
[TBL] [Abstract][Full Text] [Related]
14. β-Casomorphin-7 attenuates the development of nephropathy in type I diabetes via inhibition of epithelial-mesenchymal transition of renal tubular epithelial cells.
Zhang W; Miao J; Ma C; Han D; Zhang Y
Peptides; 2012 Aug; 36(2):186-91. PubMed ID: 22687367
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-630 alleviates inflammatory reactions in rats with diabetic kidney disease by targeting toll-like receptor 4.
Wu QS; Zheng DN; Ji C; Qian H; Jin J; He Q
World J Diabetes; 2024 Mar; 15(3):488-501. PubMed ID: 38591087
[TBL] [Abstract][Full Text] [Related]
16. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
[TBL] [Abstract][Full Text] [Related]
17. Delayed treatment with human umbilical cord blood-derived stem cells attenuates diabetic renal injury.
Park JH; Park J; Hwang SH; Han H; Ha H
Transplant Proc; 2012 May; 44(4):1123-6. PubMed ID: 22564642
[TBL] [Abstract][Full Text] [Related]
18. Alpha lipoamide inhibits diabetic kidney fibrosis via improving mitochondrial function and regulating RXRα expression and activation.
Zhang HF; Liu HM; Xiang JY; Zhou XC; Wang D; Chen RY; Tan WL; Liang LQ; Liu LL; Shi MJ; Zhang F; Xiao Y; Zhou YX; Zhang T; Tang L; Guo B; Wang YY
Acta Pharmacol Sin; 2023 May; 44(5):1051-1065. PubMed ID: 36347997
[TBL] [Abstract][Full Text] [Related]
19. 1,25(OH)
Liu P; Li F; Xu X; Li S; Dong X; Chen L; Bai B; Wang Y; Qiu M; Dong Y
Exp Mol Pathol; 2020 Jun; 114():104434. PubMed ID: 32240615
[TBL] [Abstract][Full Text] [Related]
20. USP22 aggravated diabetic renal tubulointerstitial fibrosis progression through deubiquitinating and stabilizing Snail1.
Zhao X; He X; Wei W; Huang K
Eur J Pharmacol; 2023 May; 947():175671. PubMed ID: 37001578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
